LMO1 and acute lymphoblastic leukemia: A similar study showed a C > T somatic mutation at an enhancer region of LMO1, suggested to originate from an APOBEC-like cytidine deaminase mutational signature, that created a MYB transcription factor binding site which increased expression and dependency on LMO1 in T-ALL [51].